Ginkgo biloba: A Cognitive Enhancer?

Psychological Science in the Public Interest

Volumn 3, Issue 1, 2002, Pages 2-11

  Gold, Paul E ^a   Cahill, Larry ^b   Wenk, Gary L ^c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84996260407     PISSN: 15291006     EISSN: 15396053     Source Type: Journal    
DOI: 10.1111/1529-1006.00006     Document Type: Article

References (59)

1. Ahlemeyer B. Möwes A. Krieglstein J.(1999). Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. European Journal of Pharmacology, 367, 130–423.
2. Allain H. Raoul P. Lieury A. LeCoz F. Gandon J.-M. d'Arbigny P.(1993). Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clinical Therapeutics: The International Journal of Drug Therapy, 19, 549–558.
3. Bolanos-Jimenez F. Manhaes de Castro R. Sarhan H. Prudhomme N. Drieu K. Fillion G.(1995). Stress-induced 5-HT1A receptor desensitization: Protective effects of Ginkgo biloba extract (EGb 761). Fundamental & Clinical Pharmacology, 9, 169–174.
4. Cahill L.(1999). A neurobiological perspective on emotionally influenced, long-term memory. Seminars in Clinical Neuropsychiatry, 4, 266–273.
5. Cahill L. Alkire M.(2000). Epinephrine enhancement of human memory consolidation. Society for Neuroscience Abstracts, 26, 707.
6. Cahill L. McGaugh J.L. (1996). Modulation of memory storage. Current Opinion in Neurobiology, 6, 237–242.
7. Cahill L. McGaugh J.L. (1998). Mechanisms of emotional arousal and lasting declarative memory. Trends in Neuroscience, 21, 294–299.
8. Chen C. Wei T.T. Gao Z.H. Zhao B.L. Hou J.W. Xu H.B. Xin W.J. Packer L.(1999). Different effects of the constituents of EGb 761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals. Biochemistry and Molecular Biology International, 47, 397–405.
9. Chermat R. Brochet D. DeFeudis F.V. Drieu K.(1997). Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl beta-carboline-3-carboxylate on social behavior of the rat. Pharmacology, Biochemistry & Behavior, 56, 333–339.
10. Chopin P. Briley M.(1992). Effects of four non-cholinergic enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology, 106, 26–30.
11. Christen Y. Costentin J. Lacour M.(Eds.). (1992). Effects of Ginkgo biloba extract (Egb 761) on the central nervous system. Paris: Elsevier.
12. Cohen-Salmon C. Venault P. Martin B. Raffalli-Sebille M.J. Barkats M. Clostre F. Pardon M.C. Christen Y. Chapouthier G.(1997). Effects of Ginkgo biloba (EGb 761) on learning and possible actions on aging. Journal of Physiology, 91, 291–300.
13. Cupp M.J. (1999). Herbal remedies: Adverse effects and drug interactions. American Family Physician, 59, 1239–1245.
14. Defeudis F. Bonnot D. Hörr R.(1999). Ginkgo biloba extract (EGb 761) rationale for use as a treatment for Alzheimer's Disease. In Ed. Vellas B. Fitten L.J. (Eds.), Research and practice in Alzheimer's Disease (Vol. 2, pp. 288–298). New York: Springer.
15. Fourtillan J.B., Brisson A.M., Girault J., Ingrand I., Decourt J.P., Drieu K., Jouenne P., Biber A. (1995). Proprietes pharmacocinetiques du Bilobalide et des Ginkgolides A et B chez le sujet sain apres administrations intraveineuses et orales d'extrait de Ginkgo biloba (EGb 761) [Pharmacokinetic properties of bilobalide and ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract]. Therapie, 50, 137–144.
16. Friedlich A.L., Butcher L.L. (1994). Involvement of free oxygen radicals in B-Amyloidosis: An hypothesis. Neurobiology of Aging, 15, 443–455.
17. Fugh-Berman A., Cott J.M. (1999). Dietary supplements and natural products as psychotherapeutic agents. Psychosomatic Medicine, 61, 712–728.
18. Gajewski A., Hensch S.A. (1999). Ginkgo biloba and memory for a maze. Psychological Reports, 84, 481–484.
19. Gold P.E. (2001). Drug enhancement of memory in aged rodents and humans. In Ed. Carroll M.E., Overmier J.B. (Eds.), Animal research and human health: Advancing human welfare through behavioral science (pp. 293–304). Washington, DC: American Psychological Association.
20. Gsell W., Reichert N., Youdim M.B., Riederer P. (1995). Interaction of neuro-protective substances with human brain superoxide dismutase: An in vitro study. Journal of Neural Transmission. Supplementum, 45, 271–279.
21. Hasenöhrl R.U.,Nichau Ch. Frisch Ch. De Souza Silva M.A., Huston J.P., Mattern C.M., Haecker R. (1996). Anxiolytic-like effects of combined extracts of Zingiber officinale and Ginkgo biloba in the elevated plus maze. Pharmacology, Biochemistry & Behavior, 53, 271–275.
22. Hasenöhrl R.U., Topic B., Frisch Ch. Haecker R., Mattern C.M., Huston J.P. (1998). Dissociation between anxiolytic and hypomnestic effects for combined extracts of zingiber officinale and Ginkgo biloba as opposed to diazepam. Pharmacology, Biochemistry & Behavior, 59, 527–535.
23. Hindmarch I. (1986). Activite de l'extrait de Ginkgo biloba sur la memoire a court terme [Activity of Ginkgo biloba extract on short-term memory]. Presse Medicale, 15, 1592–1594.
24. Huguet F., Drieu K., Piriou A. (1994). Decreased cerebral 5-HT1A receptors during ageing: Reversal by Ginkgo biloba extract (EGb761). Journal of Pharmacy & Pharmacology, 46, 316–318.
25. Huguet F., Tarrade T. (1992). Alpha 2-adrenoceptor changes during cerebral aging: The effect of Ginkgo biloba extract. Journal of Pharmacy & Pharmacology, 44, 24–27.
26. Joyeux M., Lobstein A., Anton R., Mortier F. (1995). Comparative antilipid peroxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo biloba. Planta Medica, 61, 126–129.
27. Kennedy D.O., Scholey A.B., Wesnes K.A. (2000). The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology, 151, 416–423.
28. Korol D.L., Gold P.E. (1998). Glucose, memory and aging. The American Journal of Clinical Nutrition, 67, 764S–771S.
29. Krieglstein J., Ausmeier F., El-Abhar H., Lippert K., Welsch M., Rupalla K., Henrich-Noack P. (1995). Neuroprotective effects of Ginkgo biloba constituents. European Journal of Pharmaceutical Sciences, 3, 39–48.
30. Kristofikova Z. (1997). In vitro effect of Ginkgo biloba extract (Egb761) on the activity of presynaptic cholinergic nerve terminals in rat hippocampus. Dementia & Geriatric Cognitive Disorders, 8, 43–48.
31. Kuenkel H. (1993). EEG profile of three different extractions of Ginkgo bi-loba. Neuropsychobiology, 27, 40–45.
32. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia: North American EGb study group. Journal of the American Medical Association, 278, 1327–1332.
33. Major R.T. (1967). The ginkgo, the most ancient living tree: The resistance of Ginkgo biloba L. to pests accounts in part for the longevity of this species. Science, 157, 1270–1273.
34. Manning C.A., Ragozzino M., Gold P.E. (1993). Glucose enhancement of memory in patients with Alzheimer's disease. Neurobiology of Aging, 14, 523–528.
35. McNay E.C., Fries T.M., Gold P.E. (2000). Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proceedings of the National Academy of Sciences, USA, 97, 2881–2885.
36. Oberpichler H., Beck T., Abdel-Rahman M.M., Bielenberg G.W., Krieglstein J. (1988). Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacological Research Communications, 20, 349–368.
37. Oken B.S., Storzbach D.M., Kaye J.A. (1998). The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Archives of Neurology, 55, 1409–1415.
38. Oyama Y., Chikahisaa L., Uehaa T., Kanemaruc K., Nodac K. (1996). Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Research, 712, 349–352.
39. Petkov V.D., Kehayov R., Belcheva S., Konstantinova E., Petkov V.V., Getova D., Marovska V. (1993). Memory effects of standardized extracts of Panax ginseng (G115), Ginkgo biloba (GK 501) and their combination Gincosan (PHL-00701). Planta Medica, 59, 106–114.
40. Porsolt R.D., Martin P., Lenegre A., Fromage S., Drieu K. (1990). Effects of an extract of Ginkgo biloba (EGB 761) on “learned helplessness” and other models of stress in rodents. Pharmacology, Biochemistry & Behavior, 36, 963–971.
41. Rai G.S., Shovlin C., Wesnes K.A. (1991). A double-blind placebo controlled study of Ginkgo biloba extract (“tanakan”) in elderly outpatients with mild to moderate memory impairment. Current Medical Research Opinions, 12, 350–355.
42. Ramassamy C., Christen Y., Clostre F., Costentin J. (1992). The Ginkgo biloba extract, Egb761, increases synaptosomal uptake of 5-hydrox-ytryptamine: In vitro and ex vivo studies. Journal of Pharmacy & Pharmacology, 44, 943–945.
43. Rapin J.R., Le Poncin Lafitte M. (1986). Consommation cerebrale du glucose. Effet de l'extrait de Ginkgo biloba [Cerebral glucose consumption: The effect of Ginkgo biloba extract]. Presse Medicale, 15, 1494–1497.
44. Rapin J.R., Zaibi M., Drieu K. (1998). In vitro and in vivo effects of an extract of Ginkgo biloba (EGb 761), ginkgolide B, and bilobalide on apoptosis in primary cultures of rat hippocampal neurons. Drug Development Research, 45, 23–29.
45. Rodriguez de Turco E.B., Droy-Lefaix M.T., Bazan N.G. (1993). Decreased electroconvulsive shock-induced diacylglycerols and free fatty acid accumulation in the rat brain by Ginkgo biloba extract (EGb 761): Selective effect in hippocampus as compared with cerebral cortex. Journal of Neurochemistry, 61, 1438–1444.
46. Sasaki K., Hatta S., Haga M., Ohshika H. (1999). Effects of bilobalide on gamma-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain. European Journal of Pharmacology, 367, 165–173.
47. Satyan K.S., Jaiswal A.K., Ghosal S., Bhattacharya S.K. (1998). Anxiolytic activity of ginkgolic acid conjugates from Indian Ginkgo biloba. Psychopharmacology, 136, 148–152.
48. Seif-El-Nasr M., El-Fattah A.A. (1995). Lipid peroxide, phospholipids, glutathione levels and superoxide dismutase activity in rat brain after ischaemia: Effect of ginkgo biloba extract. Pharmacological Research, 32, 273–278.
49. Shen J.G., Zhou D.Y. (1995). Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury. Biochemistry & Molecular Biology International, 35, 125–134.
50. Smith P.F., MacLennan K., Darlington C.L. (1996). The neuroprotective properties of the Ginkgo biloba leaf: A review of the possible relationship to platelet-activating factor (PAF). Journal of Ethnopharmacology, 50, 131–139.
51. Stoll S., Scheuer K., Pohl O., Muller W.E. (1996). Gingko biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry, 29, 144–149.
52. Trovero F., Brochet D., Tassin J.P., Drieu K. (1999). Ginko biloba extract Egb761 reduces the development of amphetamine-induced behavioral sensitization: Effects on hippocampal type II corticosteroid receptors. Brain Research, 818, 135–139.
53. van Dongen M.J.van Rossum E., Kessels A., Sielhorst H., Knipschild P. (2000). The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. Journal of the American Geriatrics Society, 48, 1183–1194.
54. Wesnes K.A., Ward T., McGinty A., Petrini O. (2000). The memory enhancing effects of a Gingko biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology, 152, 353–361.
55. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. (1981). Alzheimer Disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Annals of Neurology, 10, 122–126.
56. Winter E. (1991). Effects of an extract of Ginkgo biloba (EGb 761) on learning and memory in mice. Pharmacology, Biochemistry & Behavior, 38, 109–114.
57. Winter J.C. (1998). The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiology & Behavior, 63, 425–433.
58. Wirth S., Stemmeline J., Will B., Christen Y., Di Scala G. (2000). Facilitative effects of EGb 761 on olfactory recognition in young and aged rats. Pharmacology, Biochemistry & Behavior, 65, 321–326.
59. Zhou L.J., Song W., Zhu X.Z., Chen Z.L., Yin M.L., Cheng X.F. (2000). Protective effect of bilobalide on amyloid beta-peptide 25-35-induced PC12 cell cytotoxicity. Acta Pharmacologica Sinica, 21, 75–79.